{
  "retracted": false,
  "timestamp": 1546819200000,
  "updates": [
    {
      "timestamp": 1550539210798,
      "identifier": {
        "doi": "10.1038/s41380-018-0311-2"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41380-018-0256-5"
  },
  "journal": "Molecular Psychiatry",
  "publisher": "Springer Nature",
  "title": "Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)"
}
